NCT04678856: A reported trial by Sanofi
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT04678856 |
|---|---|
| Title | A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Uncontrolled, Chronic Rhinosinusitis Without Nasal Polyposis (CRSsNP) |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 2, 2020 |
| Completion date | Nov. 14, 2023 |
| Required reporting date | Nov. 13, 2024, midnight |
| Actual reporting date | Nov. 12, 2024 |
| Date last checked at ClinicalTrials.gov | Dec. 3, 2025 |
| Days late | None |